Mullins Kevin Michael has filed 6 insider transactions across 1 company since March 2024.
Most recent transaction: a sale of 85093 shares of LifeStance Health Group, Inc. ($LFST) on June 11, 2024.
Activity breakdown: 0 open-market purchases and 4 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 11, 2024 | LifeStance Health Group, Inc. | $LFST | Mullins Kevin Michael | Chief Development Officer | S | Common Stock | 85093 | $5.53 | 4,650,571.0000 | 0 | 1.80% | 0.00% |
| April 1, 2024 | LifeStance Health Group, Inc. | $LFST | Mullins Kevin Michael | Chief Development Officer | S | Common Stock | 9688 | $5.93 | 4,735,664.0000 | 0 | 0.20% | 0.00% |
| March 14, 2024 | LifeStance Health Group, Inc. | $LFST | Mullins Kevin Michael | Chief Development Officer | S | Common Stock | 44540 | $6.33 | 4,745,352.0000 | 0 | 0.93% | 0.00% |
| March 8, 2024 | LifeStance Health Group, Inc. | $LFST | Mullins Kevin Michael | Chief Development Officer | A | Common Stock | 124826 | $0.00 | 4,700,306.0000 | 0 | 2.73% | 0.00% |
| March 8, 2024 | LifeStance Health Group, Inc. | $LFST | Mullins Kevin Michael | Chief Development Officer | A | Common Stock | 89586 | $0.00 | 4,789,892.0000 | 0 | 1.91% | 0.00% |
| March 1, 2024 | LifeStance Health Group, Inc. | $LFST | Mullins Kevin Michael | Chief Development Officer | S | Common Stock | 115136 | $8.02 | 4,575,480.0000 | 0 | 2.45% | 0.00% |